Protara Therapeutics Financial Health

Short Term Liabilities: TARA's short term assets ($98.7M) exceed its short term liabilities ($3.7M).

Long Term Liabilities: TARA's short term assets ($98.7M) exceed its long term liabilities ($5.7M).

Debt Level: TARA is debt free.

Reducing Debt: TARA had no debt 5 years ago.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: TARA has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: TARA has sufficient cash runway for 1.8 years if free cash flow continues to reduce at historical rates of 42.4% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.